Overview
ABT market data
Price History
ABT price chart · 1M
- O
- 110.97
- H
- 111.96
- L
- 108.09
- C
- 108.79
- Vol
- 215,257.00
- Source
- US equities market feed
- Observed
- Sep 3, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $110.97
- Previous Close
- $110.46
- Day High
- $111.96
- Day Low
- $108.09
- 52 Week High
- $117.32
- 52 Week Low
- $81.39
- 7 Day Return
- -2.48%
- 30 Day Return
- +3.14%
- 90 Day Return
- +20.32%
- 1 Year Return
- +26.00%
- Daily Notional Volume
- $23.4M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 35.52 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.73 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.54 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 2.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 11.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $81.97 – $137.49 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $192.7B · P/B 4.18 · P/S 4.14.
Company News
10 captured
If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term PortfolioThe Motley Fool · Sep 2, 2026, 7:15 PM
National Advertising Division Finds Certain Kendamil Infant Formula Claims Supported; Recommends Others Be Modified or DiscontinuedGlobenewswire Inc · Aug 31, 2026, 2:15 PM
Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035Globenewswire Inc · Aug 31, 2026, 11:00 AM
Abbott (ABT) Stock Sinks As Market Gains: Here's WhyZacks Investment Research · Aug 27, 2026, 11:15 PM
Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsightGlobenewswire Inc · Aug 27, 2026, 5:30 PM
Laboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS InsiderGlobenewswire Inc · Aug 27, 2026, 3:15 PM
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingBenzinga · Aug 26, 2026, 1:36 PM
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and MedtronicGlobenewswire Inc · Aug 26, 2026, 12:15 PM
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy.The Motley Fool · Aug 26, 2026, 11:15 AM
FDA Authorizes Abbott's Libre Duo, First Device To Continuously Monitor Both Glucose And KetonesBenzinga · Aug 25, 2026, 6:35 PM